US Suits take aim at J&J diabetes drug Invokana
By Charles Toutant, From New Jersey Law Journal Johnson & Johnson faces allegations in a pair of suits filed March 30 that users of its popular diabetes drug, Invokana, develop kidney damage and heart disease. The latest filings bring the…
Are big verdicts a sign Johnson & Johnson has ‘lost its way’?
By Charles Toutant and Max Mitchell, From New Jersey Law Journal Plaintiffs lawyers haven been winning a steady stream of big products liability verdicts against Johnson & Johnson recently, and some have suggested the company’s size makes it a bigger…